Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Predictive Oncology Inc.Financial_Report.xls
10-K - FORM 10-K - Predictive Oncology Inc.v309228_10-k.htm
EX-14.1 - EXHIBIT 14.1 - Predictive Oncology Inc.v308228_ex14-1.htm
EX-31.2 - EXHIBIT 31.2 - Predictive Oncology Inc.v308228_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Predictive Oncology Inc.v308228_ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - Predictive Oncology Inc.v308228_ex23-1.htm

  

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of BioDrain Medical, Inc. (the "Company") for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kevin R. Davidson., Chief Executive Officer and Chief Financial Officer, of the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that to my knowledge:

 

(1)  The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

 

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 16, 2012

 

/s/ Kevin R. Davidson

Kevin R. Davidson

Chief Executive Officer and Chief Financial Officer

(Principal Executive Officer and Principal Financial Officer)